Abstract
In response to a university-based serogroup B meningococcal disease outbreak, the serogroup B meningococcal vaccine Trumenba was recommended for students, a rare instance in which a specific vaccine brand was recommended. This outbreak highlights the challenges of using molecular and immunologic data to inform real-time response.
Cite
CITATION STYLE
Soeters, H. M., Dinitz-Sklar, J., Kulkarni, P. A., Macneil, J. R., McNamara, L. A., Zaremski, E., … Montana, B. (2017, May 1). Serogroup B meningococcal disease vaccine recommendations at a university, New Jersey, USA, 2016. Emerging Infectious Diseases. Centers for Disease Control and Prevention (CDC). https://doi.org/10.3201/eid2305.161870
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
